Shenzhen Neptunus Bioengineering Co., Ltd. (000078.SZ)
CNY 2.81
(-1.05%)
CNY 2.81
(-1.05%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -410.18 Million | -64.32 Million | 866.12 Million | 1.65 Billion | 2.26 Billion | -1.13 Billion |
| Net Income | -1.71 Billion | -992.13 Million | 257.86 Million | -41.28 Million | 552.84 Million | 693.34 Million |
| Depreciation & Amortization | 283.91 Million | 276.15 Million | 269.23 Million | 194.29 Million | 151.55 Million | 131.26 Million |
| Deferred income taxes | 86.7 Million | -88.37 Million | 37.2 Million | -10.96 Million | -66.98 Million | -113.31 Million |
| Stock-based compensation | - | - | - | -22.91 Million | 22.91 Million | - |
| Change in working capital | -1.34 Billion | -1.26 Billion | -767.89 Million | -121.76 Million | 84.86 Million | -2.98 Billion |
| Other non-cash items | 964.26 Million | 1.91 Billion | 1.1 Billion | 1.65 Billion | 1.52 Billion | 1.02 Billion |
| Investing Cash Flow | -140.42 Million | -275.1 Million | -609.19 Million | -231.19 Million | -327.04 Million | -1.74 Billion |
| Investments in PPE | -104.07 Million | -94.31 Million | -129.22 Million | -147.29 Million | -167.53 Million | -213.51 Million |
| Acquisitions | -81.51 Million | -138 Million | -495.51 Million | 92.22 Million | -401.05 Million | -370.9 Million |
| Investment purchases | -749.86 Million | -166.75 Million | -230.42 Million | -281.63 Million | -53.27 Million | -2.55 Million |
| Sales/Maturities of investments | 791.55 Million | 113.44 Million | 244.47 Million | 102.87 Million | 38.84 Million | 18.26 Million |
| Other Investing Activities | 417.86 Thousand | 10.52 Million | 1.5 Million | 2.63 Million | 255.97 Million | -1.17 Billion |
| Financing Cash Flow | 724.84 Million | 322.1 Million | -767.59 Million | -1.3 Billion | -1.84 Billion | 2.34 Billion |
| Debt repayment | -232.5 Million | -7.93 Billion | -11.76 Billion | -15.51 Billion | -17.29 Billion | -3.19 Billion |
| Dividends payments | -553.83 Million | -648.16 Million | -565.17 Million | -771.86 Million | -55.25 Million | -1.16 Billion |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 1.18 Billion | 8.9 Billion | 11.56 Billion | 14.98 Billion | 16.79 Billion | 222.5 Million |
| Accounts receivables | -584.56 Million | -449.98 Million | 384.6 Million | 506.44 Million | 1.84 Billion | -3.94 Billion |
| Accounts payables | -1.33 Billion | -320.72 Million | -1.3 Billion | -433 Million | -1.87 Billion | 1.27 Billion |
| Inventory | 478.59 Million | -401.86 Million | 111.01 Million | -184.23 Million | 227.51 Million | -203.68 Million |
| Other working capital | -1.24 Billion | -88.37 Million | 37.2 Million | -10.96 Million | -104.92 Million | -2.78 Billion |
| Cash at beginning of period | 962.5 Million | 979.82 Million | 1.49 Billion | 1.37 Billion | 1.27 Billion | 1.81 Billion |
| Cash at end of period | 1.13 Billion | 962.5 Million | 979.82 Million | 1.49 Billion | 1.37 Billion | 1.27 Billion |
| Capital Expenditure | -104.07 Million | -94.31 Million | -129.22 Million | -147.29 Million | -167.53 Million | -213.51 Million |
| Effect of forex changes on cash | - | - | 0.27 | 0.16 | - | - |
| Net cash flow / Change in cash | 174.22 Million | -17.32 Million | -510.66 Million | 113.12 Million | 99.48 Million | -540.47 Million |
| Free Cash Flow | -514.26 Million | -158.64 Million | 736.89 Million | 1.5 Billion | 2.1 Billion | -1.34 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 807.49 Thousand | 2.76 Million | 42.64 Million | -1.77 Billion | -1.71 Billion | 803.35 Thousand |
| Depreciation & Amortization | - | 60.22 Million | 60.22 Million | 283.91 Million | 283.91 Million | -116.46 Million |
| Deferred income taxes | - | - | - | - | 86.7 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -257.95 Million | - | -105.96 Million | -1.34 Billion | 132.46 Million |
| Other non-cash items | -63.56 Million | 117.63 Million | 14.11 Million | 1.01 Billion | 964.26 Million | -58.43 Million |
| Investing Cash Flow | 28.04 Million | -52.64 Million | -33.18 Million | 143.35 Million | -140.42 Million | -27.65 Million |
| Investments in PPE | -26.62 Million | -34.51 Million | -24.82 Million | -29.01 Million | -104.07 Million | -23.74 Million |
| Acquisitions | 28.13 Million | -13.87 Million | -14 Million | -2.33 Million | -81.51 Million | -17.1 Million |
| Investment purchases | - | -188.22 Million | -96.09 Million | -742.54 Million | -749.86 Million | -1 Million |
| Sales/Maturities of investments | 26.54 Million | 183.49 Million | 98.98 Million | 749.45 Million | 791.55 Million | 20.29 Million |
| Other Investing Activities | - | 482.65 Thousand | 10.29 Million | 170.41 Million | 417.86 Thousand | -6.09 Million |
| Financing Cash Flow | -464.21 Million | 191.3 Million | -57.85 Million | 855.86 Million | 724.84 Million | -113.63 Million |
| Debt repayment | -352.74 Million | -320.69 Million | -238.17 Million | -105.74 Million | -232.5 Million | -5.83 Billion |
| Dividends payments | - | -145.38 Million | -138.81 Million | -145.85 Million | -553.83 Million | -90.27 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -111.47 Million | 52.01 Million | 361.76 Million | 1.15 Billion | 1.18 Billion | 5.8 Billion |
| Accounts receivables | - | -439.19 Million | - | -584.56 Million | -584.56 Million | 631.11 Million |
| Accounts payables | - | - | - | - | -1.33 Billion | - |
| Inventory | - | 181.23 Million | - | 478.59 Million | 478.59 Million | -498.64 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 3.77 Billion | 1.1 Billion | 1.13 Billion | 722.54 Million | 962.5 Million | 905.45 Million |
| Cash at end of period | 3.25 Billion | 1.29 Billion | 1.1 Billion | 1.13 Billion | 1.13 Billion | 722.54 Million |
| Capital Expenditure | -26.62 Million | -34.51 Million | -24.82 Million | -29.01 Million | -104.07 Million | -23.74 Million |
| Effect of forex changes on cash | - | 358.00 | - | -2011.00 | - | -2.10 |
| Net cash flow / Change in cash | -516.03 Million | 195.23 Million | -34.27 Million | 414.18 Million | 174.22 Million | -182.91 Million |
| Free Cash Flow | -89.38 Million | 25.66 Million | 31.93 Million | -614.05 Million | -514.26 Million | -65.37 Million |
5534
4182
PNRG
1338
3360
UNT